We support private and public companies building the future of medicine
TCG Crossover “TCG X” is an investment firm based in Palo Alto, California that has $824 million in assets under management as of April 14, 2021. We are a partner to The Column Group, a leading venture capital firm focused on building innovative drug discovery companies. TCG X invests in both private and public opportunities and together both funds can support promising companies from initial inception to late-stage development. In the tradition of The Column Group, we invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines. As a reflection of our increasingly global economy, we invest in companies domiciled in the US, Europe, and China.
We believe drug development is a team sport
We value collaboration and invest heavily in our network of scientific advisors and operational executives. These thought leaders provide invaluable guidance and perspective on the manifold challenges of drug development. In addition to our industry partners, we work with our Science Network, a team of leading scientists, including Nobel Prize and Lasker Award recipients. Their expertise is an invaluable resource for both our team and our portfolio companies. We leverage TCG X resources to help portfolio companies diligence new pipeline opportunities, navigate the capital markets, execute geographic expansions, and solve the challenges inherent to developing life-changing medicines.
We invest in great science to improve human health
Our goal is to support the translation of cutting-edge science into products that will make a meaningful difference for patients. We focus on finding companies with potential to do great things and aim to be valuable partners to those intrepid innovators.